Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation

K Takahashi; PWJC Serruys; V Fuster; ME Farkouh; JA Spertus; DJ Cohen; SJ Park; D W Park; J M Ahn; Arie-Pieter Kappetein; Stuart Head; Daan Thuijs; Y Onuma; D M Kent; EW Steyerberg; David van Klaveren

doi:10.1016/s0140-6736(20)32114-0

Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation

K Takahashi, PWJC Serruys, V Fuster, ME Farkouh, JA Spertus, DJ Cohen, SJ Park, D W Park, J M Ahn, Arie-Pieter Kappetein, Stuart Head, Daan Thuijs, Y Onuma, D M Kent, EW Steyerberg, David van Klaveren

Research output: Contribution to journal › Article › Academic › peer-review

105 Citations (Scopus)

Original language	English
Pages (from-to)	1399-1412
Number of pages	14
Journal	Lancet (UK)
Volume	396
Issue number	10260
DOIs	https://doi.org/10.1016/s0140-6736(20)32114-0
Publication status	Published - 2020

Access to Document

10.1016/s0140-6736(20)32114-0

http://hdl.handle.net/1765/131634

Cite this

Takahashi, K., Serruys, PWJC., Fuster, V., Farkouh, ME., Spertus, JA., Cohen, DJ., Park, SJ., Park, D. W., Ahn, J. M., Kappetein, A-P., Head, S., Thuijs, D., Onuma, Y., Kent, D. M., Steyerberg, EW., & van Klaveren, D. (2020). Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation. Lancet (UK), 396(10260), 1399-1412. https://doi.org/10.1016/s0140-6736(20)32114-0

Takahashi, K ; Serruys, PWJC ; Fuster, V et al. / Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation. In: Lancet (UK). 2020 ; Vol. 396, No. 10260. pp. 1399-1412.

@article{cd44331783ba4f878ad5f4262abc0c39,

title = "Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation",

author = "K Takahashi and PWJC Serruys and V Fuster and ME Farkouh and JA Spertus and DJ Cohen and SJ Park and Park, {D W} and Ahn, {J M} and Arie-Pieter Kappetein and Stuart Head and Daan Thuijs and Y Onuma and Kent, {D M} and EW Steyerberg and {van Klaveren}, David",

year = "2020",

doi = "10.1016/s0140-6736(20)32114-0",

language = "English",

volume = "396",

pages = "1399--1412",

journal = "Lancet (UK)",

issn = "0140-6736",

publisher = "Elsevier Ltd.",

number = "10260",

}

Takahashi, K, Serruys, PWJC, Fuster, V, Farkouh, ME, Spertus, JA, Cohen, DJ, Park, SJ, Park, DW, Ahn, JM, Kappetein, A-P, Head, S, Thuijs, D, Onuma, Y, Kent, DM, Steyerberg, EW & van Klaveren, D 2020, 'Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation', Lancet (UK), vol. 396, no. 10260, pp. 1399-1412. https://doi.org/10.1016/s0140-6736(20)32114-0

Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation. / Takahashi, K; Serruys, PWJC; Fuster, V et al.
In: Lancet (UK), Vol. 396, No. 10260, 2020, p. 1399-1412.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation

AU - Takahashi, K

AU - Serruys, PWJC

AU - Fuster, V

AU - Farkouh, ME

AU - Spertus, JA

AU - Cohen, DJ

AU - Park, SJ

AU - Park, D W

AU - Ahn, J M

AU - Kappetein, Arie-Pieter

AU - Head, Stuart

AU - Thuijs, Daan

AU - Onuma, Y

AU - Kent, D M

AU - Steyerberg, EW

AU - van Klaveren, David

PY - 2020

Y1 - 2020

U2 - 10.1016/s0140-6736(20)32114-0

DO - 10.1016/s0140-6736(20)32114-0

M3 - Article

SN - 0140-6736

VL - 396

SP - 1399

EP - 1412

JO - Lancet (UK)

JF - Lancet (UK)

IS - 10260

ER -

Takahashi K, Serruys PWJC, Fuster V, Farkouh ME, Spertus JA, Cohen DJ et al. Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation. Lancet (UK). 2020;396(10260):1399-1412. doi: 10.1016/s0140-6736(20)32114-0